New report examines impact of Affordable Care Act on national immunization policy

NewsGuard 100/100 Score

A new report issued by the George Washington University School of Public Health and Health Services and funded by the U.S. Department of Health and Human Services analyzes the impact of Affordable Care Act on national immunization policy. The report examines a wide range of reforms that are aimed at strengthening immunization policy and practice.

"Our analysis shows the extent to which immunization policy reform has emerged as a key component of health reform," noted Alexandra M. Stewart, JD, Assistant Professor of Health Policy and lead author of the report.

Sara Rosenbaum, JD, Hirsch Professor of Health Law & Policy and senior author of the report added, "The implications of the Affordable Care Act for access to and improvements in the timeliness and quality of immunization practice are far-reaching for the entire population."

The report identifies numerous provisions of the Affordable Care Act that will affect insurance coverage and affordability, access to immunization services, and the level of national investment in community prevention, wellness, and primary care.

Source: George Washington University Medical Center

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Measles and rubella vaccine delivered via microarray patch shows promising results